Methamphetamine and lentivirus interactions: Reciprocal enhancement of central nervous system disease

References

• Abbruzzese G, Rizzo F, Dall'Agata D, Morandi N, Favale E (1990). Generalized dystonia with bilateral striatal computed-tomographic lucencies in a patient with human immunodeficiency virus infection. Eur Neurol 30: 271–273.
   Google Scholar
• Albers DS, Sonsalla PK (1995). Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J Pharmacol Exp Ther 275: 1104–1114.
   PubMed Web of Science ®Google Scholar
• Angrist B (1994). Amphetamine psychosis: clinical variation of the syndrome. San Diego: Academic Press.
   Google Scholar
• Barr MC, Billaud JN, Selway DR, Huitron-Resendiz S, Osborn KG, Henriksen SJ, Phillips TR (2000a). Effects of multiple acute morphine exposures on feline immunodeficiency virus disease progression. J Infect Dis 182: 725–732.
   Google Scholar
• Barr MC, Huitron-Resendiz S, Sanchez-Alavez M, Henriksen SJ, Phillips TR (2003). Escalating morphine exposures followed by withdrawal in feline immunodeficiency virus-infected cats. Drug Alcohol Depend 72: 141–149.
   Google Scholar
• Barr MC, Huitron-Resendiz S, Selway DR, Henriksen SJ, Phillips TR (2000b). Exogenous glucocorticoids alter parameters of early feline immunodeficiency virus infection. J Infect Dis 181: 576–586.
   Google Scholar
• Bell JE, Brettle RP, Chiswick A, Simmonds P (1998). HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121(Pt 11): 2043–2052.
   Google Scholar
• Berger JR, Nath A (1997). HIV dementia and the basal ganglia. Intervirology 40: 122–131.
   PubMedGoogle Scholar
• Bouwman FH, Skolasky RL, Hes D, Selnes OA, Glass JD, Nance-Sproson TE, Royal W, Dal Pan GJ, McArthur JC (1998). Variable progression of HIV-associated dementia. Neurology 50: 1814–1820.
   PubMed Web of Science ®Google Scholar
• Broening HW, Pu C, Vorhees CV (1997). Methamphetamine selectively damages dopaminergic innervation to the nucleus accumbens core while sparing the shell. Synapse 27: 153–160.
   Google Scholar
• Callahan B, Yuan J, Stover G, Hatzidimitriou G, Ricaurte G (1998). Effects of 2-deoxy-D-glucose on methamphetamine-induced dopamine and serotonin neurotoxicity. J Neurochem 70: 190–197.
   Google Scholar
• Cappon GD, Morford LL, Vorhees CV (1997). Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response. Brain Res Dev Brain Res 103: 155–162.
   PubMedGoogle Scholar
• Cass WA, Harned ME, Peters LE, Nath A, Maragos WF (2003). HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat. Brain Res 984: 133–142.
   PubMed Web of Science ®Google Scholar
• Cass WA, Manning MW (1999). Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. J Neurosci 19: 7653–7660.
   Google Scholar
• Castello E, Baroni N, Pallestrini E (1998). Neurotological auditory brain stem response findings in human immunodeficiency virus-positive patients without neurologic manifestations. Ann Otol Rhinol Laryngol 107: 1054–1060.
   Google Scholar
• Cazzullo CL, Gala C, Ducati A, Landi A, Donati R, Russo R, Rossini M, Nicolosi A (1990). Multimodality evoked potentials in HIV infected subjects: a longitudinal study. Ital J Neurol Sci 11: 481–485.
   Google Scholar
• Chang L, Ernst T, Speck O, Grob CS (2005). Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry 162: 361–369.
   PubMed Web of Science ®Google Scholar
• Christensen LA, Morehouse CR, Powell TW, Alchediak T, Silio M (1998). Antiviral therapy in a child with pediatric human immunodeficiency virus (HIV): case study of audiologic findings. J Am Acad Audiol 9: 292–298.
   PubMedGoogle Scholar
• Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS (1987). Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241: 338–345.
   PubMed Web of Science ®Google Scholar
• Corsi KF, Booth RE (2008). HIV sex risk behaviors among heterosexual methamphetamine users: literature review from 2000 to present. Curr Drug Abuse Rev 1: 292–296.
   PubMedGoogle Scholar
• Crews L, Patrick C, Achim CL, Everall IP, Masliah E (2009). Molecular pathology of Neuro-AIDS (CNS-HIV). Int J Mol Sci 10: 1045–1063.
   PubMed Web of Science ®Google Scholar
• Ellinwood EH, Jr., Escalante O (1970). Behavior and histopathological findings during chronic methedrine intoxication. Biol Psychiatry 2: 27–39.
   Google Scholar
• Everall I, Luthert P, Lantos P (1993). A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. J Neuropathol Exp Neurol 52: 561–566.
   PubMedGoogle Scholar
• Ferris MJ, Mactutus CF, Booze RM (2008). Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev 32: 883–909.
   Google Scholar
• Fox HS, Weed MR, Huitron-Resendiz S, Baig J, Horn TF, Dailey PJ, Bischofberger N, Henriksen SJ (2000). Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys. J Clin Invest 106: 37–45.
   PubMed Web of Science ®Google Scholar
• Gavrilin MA, Mathes LE, Podell M (2002). Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J NeuroVirol 8: 240–249.
   PubMed Web of Science ®Google Scholar
• Gruol DL, Yu N, Parsons KL, Billaud JN, Elder JH, Phillips TR (1998). Neurotoxic effects of feline immunodeficiency virus, FIV-PPR. J NeuroVirol 4: 415–425.
   PubMed Web of Science ®Google Scholar
• Hanson JE, Birdsall E, Seferian KS, Crosby MA, Keefe KA, Gibb JW, Hanson GR, Fleckenstein AE (2009). Methamphetamine-induced dopaminergic deficits and refractoriness to subsequent treatment. Eur J Pharmacol 607: 68–73.
   Google Scholar
• Hausler R, Vibert D, Koralnik IJ, Hirschel B (1991). Neuro-otological manifestations in different stages of HIV infection. Acta Otolaryngol Suppl 481: 515–521.
   Google Scholar
• Henriksen SJ, Prospero-Garcia O, Phillips TR, Fox HS, Bloom FE, Elder JH (1995). Feline immunodeficiency virus as a model for study of lentivirus infection of the central nervous system. In: Current topics in microbiology and immunology: HIV and dementia. Oldstone MBA, Vitkovic L ( eds). Springer, Berlin, Germany. pp 167–186.
   Google Scholar
• Jaffe J (1990). Drug addiction and drug abuse. In: The pharmacological basis of therapeutics, 8th ed. Alfred G Gilman, Alan S Nies, Theodore W Rall, Palmer Tayler (eds). New York: McGraw-Hill, pp 522–573.
   Google Scholar
• Kipke MD, O'Connor S, Palmer R, MacKenzie RG (1995). Street youth in Los Angeles. Profile of a group at high risk for human immunodeficiency virus infection. Arch Pediatr Adolesc Med 149: 513–519.
   PubMed Web of Science ®Google Scholar
• Klein D, Leutenegger CM, Bahula C, Gold P, Hofmann-Lehmann R, Salmons B, Lutz H, Gunzburg WH (2001). Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus. J Acquir Immune Defic Syndr 26: 8–20.
   Google Scholar
• Kogan FJ, Nichols WK, Gibb JW (1976). Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur J Pharmacol 36: 363–371.
   PubMed Web of Science ®Google Scholar
• Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Masliah E (2003). Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr 34: 467–474.
   PubMed Web of Science ®Google Scholar
• Liang H, Wang X, Chen H, Song L, Ye L, Wang SH, Wang YJ, Zhou L, Ho WZ (2008). Methamphetamine enhances HIV infection of macrophages. Am J Pathol 172: 1617–1624.
   PubMed Web of Science ®Google Scholar
• Maragos WF, Young KL, Turchan JT, Guseva M, Pauly JR, Nath A, Cass WA (2002). Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J Neurochem 83: 955–963.
   PubMedGoogle Scholar
• Masliah E, Ge N, Achim CL, Hansen LA, Wiley CA (1992). Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol 51: 585–593.
   PubMed Web of Science ®Google Scholar
• Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I, Group H (1997). Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann Neurol 42: 963–972.
   PubMed Web of Science ®Google Scholar
• Meeker RB, Thiede BA, Hall C, English R, Tompkins M (1997). Cortical cell loss in asymptomatic cats experimentally infected with feline immunodeficiency virus. AIDS Res Hum Retroviruses 13: 1131–1140.
   Google Scholar
• Molitor F, Truax SR, Ruiz JD, Sun RK (1998). Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med 168: 93–97.
   PubMedGoogle Scholar
• Molliver ME, Berger UV, Mamounas LA, Molliver DC, O'Hearn E, Wilson MA (1990). Neurotoxicity of MDMA and related compounds: anatomic studies. Ann N Y Acad Sci 600: 649–661; discussion 661–644.
   PubMedGoogle Scholar
• Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL, Marcotte TD, Heaton RK, Grant I (2006). Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS 20: 879–887.
   PubMed Web of Science ®Google Scholar
• Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, Cass W, Turchan JT (2002). Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 31(Suppl 2): S62–S69.
   Google Scholar
• Nath A, Maragos WF, Avison MJ, Schmitt FA, Berger JR (2001). Acceleration of HIV dementia with methamphetamine and cocaine. J NeuroVirol 7: 66–71.
   PubMed Web of Science ®Google Scholar
• Ollo C, Johnson R, Jr., Grafman J (1991). Signs of cognitive change in HIV disease: an event-related brain potential study. Neurology 41: 209–215.
   PubMedGoogle Scholar
• Pardo J, Marcos A, Bhathal H, Castro M, Varea de Seijas E (1998). Chorea as a form of presentation of human immunodeficiency virus-associated dementia complex. Neurology 50: 568–569.
   Google Scholar
• Phillips TR, Billaud JN, Henriksen SJ (2000). Methamphetamine and HIV-1: potential interactions and the use of the FIV/cat model. J Psychopharmacol 14: 244–250.
   Google Scholar
• Phillips TR, Prospero-Garcia O, Puaoi DL, Lerner DL, Fox HS, Olmsted RA, Bloom FE, Henriksen SJ, Elder JH (1994). Neurological abnormalities associated with feline immunodeficiency virus infection. J Gen Virol 75: 979–987.
   Google Scholar
• Phillips TR, Prospero-Garcia O, Wheeler DW, Wagaman PC, Lerner DL, Fox HS, Whalen LR, Bloom FE, Elder JH, Henriksen SJ (1996). Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J NeuroVirol 2: 388–396.
   Web of Science ®Google Scholar
• Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, Trapp BD (1993). Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 34: 339–350.
   PubMed Web of Science ®Google Scholar
• Prospero-Garcia O, Gold LH, Fox HS, Polis I, Koob GF, Bloom FE, Henriksen SJ (1996). Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys. Proc Natl Acad Sci U S A 93: 14158–14163.
   PubMed Web of Science ®Google Scholar
• Prospero-Garcia O, Herold N, Phillips T, Elder J, Bloom FE, Henriksen SJ (1994a). Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc Natl Acad Sci U S A. 91: 12947–12951.
   Google Scholar
• Prospero-Garcia O, Herold N, Waters A, Phillips T, Elder J, Henriksen SJ (1994b). Intraventricular administration of a FIV-envelope protein induces sleep architecture changes in rats. Brain Res 659: 254–258.
   Google Scholar
• Prospero-Garcia O, Huitron-Resendiz S, Casalman SC, Sanchez-Alavez M, Diaz-Ruiz O, Navarro L, Lerner DL, Phillips TR, Elder JH, Henriksen SJ (1999). Feline immunodeficiency virus envelope protein (FIVgp120) causes electrophysiological alterations in rats. Brain Res 836: 203–209.
   Google Scholar
• Raymond LA, Wallace D, Berman NE, Marcario J, Foresman L, Joag SV, Raghavan R, Narayan O, Cheney PD (1998). Auditory brainstem responses in a Rhesus Macaque model of neuro-AIDS. J NeuroVirol 4: 512–520.
   Web of Science ®Google Scholar
• Reyes MG, Faraldi F, Senseng CS, Flowers C, Fariello R (1991). Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 82: 39–44.
   PubMed Web of Science ®Google Scholar
• Reyes-Contreras L, Silva-Rojas A, Ysunza-Rivera A, Jimenez-Ruiz G, Berruecos-Villalobos P, Romo-Gutierrez G (2002). Brainstem auditory evoked response in HIV-infected patients with and without AIDS. Arch Med Res 33: 25–28.
   Google Scholar
• Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY (1982). Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res 235: 93–103.
   PubMed Web of Science ®Google Scholar
• Ricaurte GA, McCann UD (1992). Neurotoxic amphetamine analogues: effects in monkeys and implications for humans. Ann N Y Acad Sci 648: 371–382.
   PubMed Web of Science ®Google Scholar
• Rotheram-Borus MJ, Cajetan Luna G, Marotta T, Kelly H (1994). Going nowhere fast: Methamphetamine use and HIV infection. NIDA Res Monogr 143: 155–182.
   Google Scholar
• Sahakian BJ, Elliott R, Low N, Mehta M, Clark RT, Pozniak AL (1995). Neuropsychological deficits in tests of executive function in asymptomatic and symptomatic HIV-1 seropositive men. Psychol Med 25: 1233–1246.
   PubMed Web of Science ®Google Scholar
• Sardar AM, Czudek C, Reynolds GP (1996). Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. Neuroreport 7: 910–912.
   Google Scholar
• Semple SJ, Strathdee SA, Zians J, Patterson TL (2009). Sexual risk behavior associated with co-administration of methamphetamine and other drugs in a sample of HIV-positive men who have sex with men. Am J Addict 18: 65–72.
   PubMed Web of Science ®Google Scholar
• Smith T, Jakobsen J, Gaub J, Helweg-Larsen S, Trojaborg W (1988). Clinical and electrophysiological studies of human immunodeficiency virus-seropositive men without AIDS. Ann Neurol 23: 295–297.
   PubMed Web of Science ®Google Scholar
• Taffe MA, Davis SA, Yuan J, Schroeder R, Hatzidimitriou G, Parsons LH, Ricaurte GA, Gold LH (2002). Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge. Neuropsychopharmacology 27: 993–1005.
   PubMedGoogle Scholar
• Theodore S, Stolberg S, Cass WA, Maragos WF (2006). Human immunodeficiency virus-1 protein tat and methamphetamine interactions. Ann N Y Acad Sci 1074: 178–190.
   Google Scholar
• Theodore S, Cass WA, Nath A, Maragos WF (2007). Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration. Curr HIV Res 5: 301–313.
   PubMedGoogle Scholar
• Vigliano P, Boffi P, Bonassi E, Gandione M, Marotta C, Raino E, Russo R, Rigardetto R (2000). Neurophysiologic exploration: a reliable tool in HIV-1 encephalopathy diagnosis in children. Panminerva Med 42: 267–272.
   Google Scholar
• Vigliano P, Russo R, Arfelli P, Boffi P, Bonassi E, Gandione M, Raino E, Tovo PA, Taglianti MV, Rigardetto R (1997). Diagnostic value of multimodal evoked potentials in HIV-1 infected children. Neurophysiol Clin 27: 283–292.
   Google Scholar
• Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J (1980). Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181: 151–160.
   PubMed Web of Science ®Google Scholar
• Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R (1991). Neocortical damage during HIV infection. Ann Neurol 29: 651–657.
   PubMed Web of Science ®Google Scholar
• Wolfson T, Velin R, Marcotte TD, Hesselink JR, Jernigan TL, Chandler J, Wallace M, Abramson I, THE HNRC GROUP (1995). The HNRC 500—neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1: 231–251.
   Google Scholar
• Woolverton WL, Ricaurte GA, Forno LS, Seiden LS (1989). Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res 486: 73–78.
   PubMed Web of Science ®Google Scholar
• Yu N, Billaud JN, Phillips TR (1998). Effects of feline immunodeficiency virus on astrocyte glutamate uptake: implications for lentivirus-induced central nervous system diseases. Proc Natl Acad Sci U S A 95: 2624–2629.
   Google Scholar